Shibbi Alexander, Agacnp, FNP

Shibbi Alexander practices at William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System.

Shibbi Alexander's NPI, 1639673551, was assigned on March 23, 2018. Shibbi Alexander holds Texas license AP137092.

Shibbi Alexander's primary practice is William P. Clements Jr. University Hospital, at 6201 Harry Hines Blvd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 633-5555.

Shibbi Alexander's primary practice is William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Shibbi Alexander to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Shibbi Alexander practices, 2 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Shibbi Alexander's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Shibbi Alexander is licensed in Texas.

CMS counts 185 Medicare patients who saw Shibbi Alexander in 2024. The largest group is 65 to 74, with 84 patients. 75% of them have diabetes, and 75% have high blood pressure. 20% are also on Medicaid. Their average risk score is 4.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Shibbi Alexander's median patient age at 60, with 47% women.

In 2024, Shibbi Alexander wrote 374 Medicare Part D claims for 92 patients. 17% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Shibbi Alexander for performance year 2024, reported as part of a group. Shibbi Alexander accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Shibbi Alexander as offering telehealth.

CMS Open Payments shows 2 general payments to Shibbi Alexander from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Tandem Diabetes Care, Inc. paid the most, $161.